Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: November 4, 2025
Reporting Period: Fiscal First Quarter ended September 30, 2025
Context: The Company issued a press release announcing preliminary, unaudited revenue results for the quarter. The Company is an emerging growth company listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text references the announcement of preliminary, unaudited revenue results but does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the body of this 8-K document. These figures are contained in the attached press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text of this filing. The document serves solely to notify investors of the issuance of the press release regarding Q1 2025 results.
Guidance, Outlook, and Risks
- Management Commentary: Limited to the announcement of the press release; no specific outlook or commentary is included in the filing text.
- Risks and Contingencies: The filing includes a standard disclaimer stating that the information is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933.
- Unusual Items: None identified in the text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 4, 2025) for the actual preliminary revenue figures and any accompanying commentary.
- Verify the unaudited nature of the reported results before making investment decisions.
- Confirm the Company's status as an emerging growth company and its implications for financial reporting standards.
- Check subsequent filings for the audited financial statements for the fiscal quarter ended September 30, 2025.